Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis, and other acid‑related disorders in adult patients.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality and regulatory compliance across markets. The company maintains a robust supply chain and adheres to EU Good Manufacturing Practice standards.

Esomeprazole is used to treat several acid‑related gastrointestinal conditions by decreasing stomach acid production. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining higher gastric pH. - Erosive oesophagitis: promotes healing of damaged esophageal lining and prevents further erosion. - NSAID‑induced gastric ulcer: protects the gastric mucosa from acid‑mediated injury associated with non‑steroidal anti‑inflammatory drugs. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion caused by gastrin‑producing tumors. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by reducing gastric acidity.

Common and serious adverse reactions have been reported with esomeprazole use.

Common Side Effects: - Headache: mild pain often occurring shortly after initiation. - Diarrhea: loose stools that may resolve with continued therapy. - Abdominal pain: discomfort or cramping in the stomach region. - Nausea: feeling of sickness or urge to vomit. - Flatulence: increased intestinal gas. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, rash, difficulty breathing. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Low serum magnesium (hypomagnesemia): muscle cramps, irregular heartbeat. - Elevated liver enzymes: signs of hepatic injury. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: widespread skin blistering. - Pancreatitis: upper abdominal pain with elevated enzymes.

Before prescribing esomeprazole, clinicians should consider several safety and handling precautions. - Assess renal function: dose adjustment may be needed in severe impairment. - Monitor magnesium levels: prolonged use can lead to hypomagnesemia. - Use with caution in hepatic impairment: drug metabolism may be altered. - Avoid in patients with known hypersensitivity to esomeprazole or other PPIs. - Consider dose reduction in elderly patients: increased susceptibility to adverse effects. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Esomeprazole may alter the plasma concentrations of several co‑administered medicines, requiring attention to interaction risk.

Major Interactions (Avoid): - Atazanavir: reduced absorption leading to loss of antiviral efficacy. - Nelfinavir: decreased plasma levels compromising HIV treatment. - Rilpivirine: impaired absorption resulting in subtherapeutic exposure. - Clopidogrel: reduced conversion to active metabolite, decreasing antiplatelet effect. - Warfarin: potential increase in INR and bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentration, may require dose adjustment. - Methotrexate: decreased renal clearance, risk of toxicity. - Ketoconazole: elevated levels due to reduced clearance. - Fluconazole: higher azole concentrations, monitor for toxicity. - Iron salts: decreased iron absorption, separate dosing by at least 2 hours.